Persistence of full-length caspase-12 and its relation to malaria in West and Central African populations
Matthew B. B. McCall1,*, Bart Ferwerda2,*, Joost Hopman1, Ivo Ploemen1, Boubacar Maiga3, Modibo Daou3, Amagana Dolo3, Cornelus C. Hermsen1, Ogobara K. Doumbo3, George Bedu-Addo4, Jos W. van der Meer2, Marita Troye-Blomberg5, André J. A. M. van der Ven2, Ralf R. Schumann6, Robert W. Sauerwein1, Frank P. Mockenhaupt7, Mihai G. Netea2
European Cytokine Network, Vol.21, No.2, pp. 77-83, 2010, DOI:10.1684/ecn.2010.0187
Abstract Background. The full-length (L-) variant of caspase-12 is believed to predispose to sepsis. It has
been replaced in the genome of most human populations by the (S-) variant, which leads to premature termination of translation. Strikingly, the L-allele is still widely prevalent in African populations, presumably due to a
counterbalancing selective force specific to this continent, for which malaria is a prime candidate. Methods. We
investigated associations between caspase-12 genotype and malarial parameters in three West-African populations, in studies encompassing immunological, clinical and obstetric data. Results. The caspase-12 L-allele was
found at frequencies of 11-34%. Plasmodium… More >